These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 7821351)
1. Role of 5-HT1A receptors in the antinociceptive action of 8-hydroxy-2-(di-n- propylamino)tetralin in the rat. Cervo L; Rossi C; Tatarczynska E; Samanin R Eur J Pharmacol; 1994 Sep; 263(1-2):187-91. PubMed ID: 7821351 [TBL] [Abstract][Full Text] [Related]
2. MKC-242, a novel 5-HT1A receptor agonist, facilitates cortical acetylcholine release by a mechanism different from that of 8-OH-DPAT in awake rats. Somboonthum P; Matsuda T; Asano S; Sakaue M; Baba A Neuropharmacology; 1997; 36(11-12):1733-9. PubMed ID: 9517445 [TBL] [Abstract][Full Text] [Related]
3. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia. Bardin L; Tarayre JP; Koek W; Colpaert FC Eur J Pharmacol; 2001 Jun; 421(2):109-14. PubMed ID: 11399266 [TBL] [Abstract][Full Text] [Related]
4. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat. Bervoets K; Rivet JM; Millan MJ J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of (R)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on the monosynaptic spinal reflex in rats. Honda M; Ono H Eur J Pharmacol; 1999 Jun; 373(2-3):171-9. PubMed ID: 10414436 [TBL] [Abstract][Full Text] [Related]
6. 8-Hydroxy-2-(di-n-propylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HT1A receptors. Carli M; Samanin R Br J Pharmacol; 1992 Mar; 105(3):720-6. PubMed ID: 1385752 [TBL] [Abstract][Full Text] [Related]
7. 8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task. Carli M; Tranchina S; Samanin R Eur J Pharmacol; 1992 Feb; 211(2):227-34. PubMed ID: 1535320 [TBL] [Abstract][Full Text] [Related]
8. Effects of the selective 5-HT1A receptor antagonist WAY100135 and its enantiomers on 8-OH-DPAT-induced hyperglycaemia in conscious rats. Critchley DJ; Middlefell VC; Liddle CW; Foden ND; Dourish CT Eur J Pharmacol; 1994 Mar; 254(1-2):133-9. PubMed ID: 8206109 [TBL] [Abstract][Full Text] [Related]
9. Antagonism of (+)WAY 100135 to behavioral, hypothermic and corticosterone effects induced by 8-OH-DPAT. Przegaliński E; Filip M; Budziszewska B; Chojnacka-Wójcik E Pol J Pharmacol; 1994; 46(1-2):21-7. PubMed ID: 7981767 [TBL] [Abstract][Full Text] [Related]
10. Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors. Luscombe GP; Martin KF; Hutchins LJ; Gosden J; Heal DJ Br J Pharmacol; 1993 Mar; 108(3):669-77. PubMed ID: 8467355 [TBL] [Abstract][Full Text] [Related]
11. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex. Borsini F; Ceci A; Bietti G; Donetti A Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):283-90. PubMed ID: 8584043 [TBL] [Abstract][Full Text] [Related]
12. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ; Bervoets K; Colpaert FC J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033 [TBL] [Abstract][Full Text] [Related]
13. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin. Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172 [TBL] [Abstract][Full Text] [Related]
14. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471 [TBL] [Abstract][Full Text] [Related]
15. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin. Chen NH; Reith ME J Neurochem; 1995 Apr; 64(4):1585-97. PubMed ID: 7891086 [TBL] [Abstract][Full Text] [Related]
16. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats. Buisson-Defferier S; Hibert M; van den Buuse M Fundam Clin Pharmacol; 1993; 7(9):499-511. PubMed ID: 7906241 [TBL] [Abstract][Full Text] [Related]
17. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses. Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846 [TBL] [Abstract][Full Text] [Related]
18. Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin. Lucot JB Eur J Pharmacol; 1994 Feb; 253(1-2):53-60. PubMed ID: 8013549 [TBL] [Abstract][Full Text] [Related]
19. 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors. Hajós-Korcsok E; Sharp T Eur J Pharmacol; 1996 Oct; 314(3):285-91. PubMed ID: 8957248 [TBL] [Abstract][Full Text] [Related]
20. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons. Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]